IMTX vs BIIB: Which Stock is Better?
Side-by-side comparison of Immatics Nv and Biogen Inc in 2026
IMTX
Immatics Nv
$10.95
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | IMTX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.46B | $25.88B | BIIB |
| P/E Ratio | N/A | 20.09 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | -0.6% | -0.1% | BIIB |
| Gross Margin | -280.9% | 78.9% | BIIB |
Analyze IMTX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMTX or BIIB a better investment?
Comparing IMTX and BIIB: Immatics Nv has a market cap of $1.46B while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMTX and BIIB?
IMTX (Immatics Nv) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMTX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMTX or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.6% for IMTX.
Which company is more profitable: IMTX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -280.9% for IMTX.
Which is the larger company: IMTX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $1.46B for IMTX.
Should I buy IMTX or BIIB in 2026?
Both IMTX and BIIB have investment merit. IMTX trades at $10.95 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMTX and BIIB stock?
Key differences: Market Cap ($1.46B vs $25.88B), P/E Ratio (N/A vs 20.1x), Revenue Growth (-0.6% vs -0.1%), Gross Margin (-280.9% vs 78.9%).